Search Results - "Noeding, S"

Abstract P1-15-10: A prospective multicenter real-world study on neoadjuvant treatment and clinical outcome in TNBC patients by Kuehnle, E, Kaur, P, Siggelkow, W, Luebbe, K, Schrader, I, Uleer, C, Noeding, S, Noeding, K-H, Noesselt, T, Arfsten, M, Busch, C, Krentel, N, Hillemanns, P, Dörk, T, Park-Simon, T-W

“…Introduction Controversy exists with regards to the optimal regimen for neoadjuvant chemotherapy (NAC) of TNBC. Platinum-based regimens seem to be more active…”
Get full text

Abstract P5-10-09: Prospective cross-sectional-study on participation in mammography screening according to immigration background and education status by Kuehnle, E, Oeztuerk, T, Siggelkow, W, Luebbe, K, Moser, A, Noeding, S, John, J, Noesselt, T, Busch, C, Arfsten, M, Lemster, S, Hillemans, P, Doerk, T, Park-Simon, T-W

“…Introduction Although the health of immigrants is an important issue in national health care policy there is a serious shortage of data in many countries. Most…”
Get full text

Gain2: Adjuvant Phase III Trial Comparing an Intensified Dose-Dense Adjuvant Therapy with Enpc Compared with a Dose-Dense, Dose-Adapted Therapy with Dtec Dtdocetaxel in Patients with Primary Breast Cancer and a High Risk of Recurrence by Noeding, S., Forstbauer, H., Wachsmann, G., Ober, A., Schneeweiss, A., Christensen, B., von Abel, E., Grischke, E., Höffkes, H., Klare, P., Ko, Y., Schmatloch, S., Burchardi, N., Loibl, S., von Minckwitz, G., Möbus, V.

Get full text

264PDGAIN2: ADJUVANT PHASE III TRIAL COMPARING AN INTENSIFIED DOSE-DENSE ADJUVANT THERAPY WITH ENPC COMPARED WITH A DOSE-DENSE, DOSE-ADAPTED THERAPY WITH DTEC DTDOCETAXEL IN PATIENTS WITH PRIMARY BREAST CANCER AND A HIGH RISK OF RECURRENCE by Noeding, S., Forstbauer, H., Wachsmann, G., Ober, A., Schneeweiss, A., Christensen, B., von Abel, E., Grischke, E., Höffkes, H., Klare, P., Ko, Y., Schmatloch, S., Burchardi, N., Loibl, S., von Minckwitz, G., Möbus, V.

“…Abstract Aim: Combined chemotherapy requires compromises in terms of dosage and treatment interval due to toxicities. The sequential administration of…”
Get full text

Inhibin A Is Downregulated during Chemotherapy in Patients with Early Breast Cancer by Rack, B., Burkhardt, N., Jueckstock, J., Kuhn, C., Noeding, S., Hoenig, A., Friedrich, M., Schindlbeck, C., Sommer, H., Friese, K., Janni, W., Mylonas, [.

“…Introduction: Inhibins are dimeric glycoproteins, composed of an alpha-subunit (INH-a) and one of two possible beta-subunits (ßA or ßB), with substantial roles…”
Get full text

Minimal residual disease detection in peripheral blood of primary breast cancer patients – translational research in the SUCCESS-study by Jenderek, C, Jückstock, J, Schindlbeck, C, Rack, B, Fuchs, R, Noeding, S, Krabisch, P, Ebner, F, Lichtenegger, W, Beckmann, MW, Friese, K, Sommer, H, Janni, W

“…Abstract #5019 Background: The detection of occult tumor cells in the bone marrow of patients with breast cancer has been shown to be an independent predictive…”
Get full text

Auftreten von equivocal Her2neu Ergebnissen nach Revision der ASCO/CAP Empfehlungen in einem Real-world-setting. Ergebnisse einer prospektiven Querschnittsstudie von Brustkrebspatienten der Region Hannover by Kühnle, E, Siggelkow, W, Luebbe, K, Schrader, I, Noeding, S, Noeding, KH, Noesselt, T, Arfsten, M, Hillemanns, P, Dörk, T, Park-Simon, TW

Get full text

Evaluation of the tumor marker Ca27.29 for risk stratification and treatment monitoring in primary breast cancer by Genss, E. M., Rack, B., Sommer, H. L., Schrader, I., Lorenz, R., Tesch, H., Söling, U., Noeding, S., Beckmann, M. W., Lichtenegger, W.

“…Abstract only 11005 Background: Several trials have shown an earlier detection of metast. disease in breast cancer pts by the use of TU- markers. Whether this…”
Get full text

Prospektive Querschnittstudie zur Anwendungshäufigkeit und Umsetzung der S3-Leitlinie an vier zertifizierten Brustzentren in Hannover und Hildesheim by Kühnle, E, Tordai, KE, Siggelkow, W, Lübbe, K, Moser, A, Noeding, S, John, J, Hillemanns, P, Öztürk, T, Dörk-Bousset, T, Park-Simon, TW

“…Zielsetzung: Die Erfüllung der im Kennzahlenbogen der Deutschen Krebsgesellschaft definierten Kennzahlen und Sollvorgaben sind die Grundlage für eine…”
Get full text

Hydrometalation. 3. Hydroalumination of alkenes and dienes catalyzed by transition metal halides by Ashby, E. C, Noding, S. A

Get full text

Alkylation of enones and ketones using substituted alkyl- and arylaluminum compounds by Ashby, E. C, Noding, S. A

Get full text